Anti-cancer drug, Genexol sold at over 10 billion won.

Published: 2006-12-27 06:58:00

Updated: 2006-12-27 06:58:00

Genexol (paclitaxel), an anti-cancer drug, was developed by Samyang and distributed by CJ, now reaching its sales to 10 billion won at the early of Dec., which may achieve 11 billion won up the end of this year.

Unlike cardiovascular and other drugs, most of anti-cancer drug markets have bee...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK